physostigmine has been researched along with Age-Related Memory Disorders in 56 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (41.07) | 18.7374 |
| 1990's | 14 (25.00) | 18.2507 |
| 2000's | 12 (21.43) | 29.6817 |
| 2010's | 6 (10.71) | 24.3611 |
| 2020's | 1 (1.79) | 2.80 |
| Authors | Studies |
|---|---|
| Darekar, MN; Gurjar, AS; Ooi, L; Yeong, KY | 1 |
| Iwasa, H; Iwasa, M; Katsuyama, S; Kurokawa, K; Miyagawa, K; Mochida-Saito, A; Nakagawasai, O; Tadano, T; Takahashi, K; Takeda, H; Tsuji, M | 1 |
| Haeri-Rouhani, SA; Javad-Moosavi, BZ; Nasehi, M; Vaezi, G; Zarrindast, MR | 1 |
| Barnet, RC; Hunt, PS | 1 |
| Bentley, P; Dolan, RJ; Driver, J | 1 |
| Ilavazhagan, G; Maiti, P; Muthuraju, S; Pati, S; Prasad, D; Sharma, AK; Singh, SB; Solanki, P | 1 |
| Araujo, JA; de Rivera, C; Greig, NH; Ingram, DK; Milgram, NW; Sandin, J | 1 |
| Hong, E; Liy-Salmeron, G; Meneses, A; Ponce-Lopez, T | 1 |
| Egashira, N; Fujiwara, M; Iwasaki, K; Matsumoto, Y; Mishima, K | 1 |
| Acosta, GB; Baratti, CM; Blake, MG; Boccia, MM | 1 |
| Arciniegas, DB; Topkoff, JL | 1 |
| Bertchume, A; Csernansky, CA; Csernansky, JG; Dong, H; Martin, MV; Vallera, D | 1 |
| Arai, Y; Hiraga, H; Mawatari, K; Murakami, H; Nakagawasai, O; Niijima, F; Sato, S; Tadano, T; Tan-No, K; Taniguchi, R; Yamadera, F | 1 |
| Chang, Q; Gold, PE | 1 |
| Jolles, J; Verhoeven, WM | 1 |
| Drachman, DA; Fleming, P; Glosser, G; Longenecker, G | 1 |
| Fuld, PA; Masur, DM; Sharpless, NS; Thal, LJ | 1 |
| Brinkman, SD; Gershon, S | 1 |
| Levin, HS; Peters, BH | 1 |
| Davis, KL; Mohs, RC | 1 |
| Davis, KL; Levy, MI; Mohs, RC; Rosen, WG | 1 |
| Beninger, RJ; Boegman, RJ; Jhamandas, K; Mallet, PE; Wirsching, BA | 1 |
| Kimura, K; Nakagawa, Y; Ogasawara, T; Tamura, M; Ukai, Y | 1 |
| Itoh, J; Kameyama, T; Ukai, M | 1 |
| Aigner, TG; Ogura, H | 1 |
| Kishi, A; Ohno, M; Watanabe, S | 1 |
| Ando, K; Hironaka, N | 1 |
| Lichtman, SW; Seliger, G; Taverni, JP | 1 |
| Garrone, B; Landolfi, C; Luparini, MR; Magnani, M; Milanese, C; Tolu, L | 1 |
| Bejar, C; Wang, RH; Weinstock, M | 1 |
| Braida, D; Sala, M | 1 |
| Nakazato, E; Ohno, M; Watanabe, S; Yamamoto, T | 1 |
| Li, Z; Pei, G; Wu, CF; Xu, NJ | 1 |
| Matsumoto, Y; Watanabe, S; Yamamoto, T; Yoshida, M | 1 |
| Smith, CM; Swash, M | 2 |
| Orbach, J; Overstreet, DH; Skinner, DM | 1 |
| Bartus, RT | 1 |
| Davis, KL; Yamamura, HI | 1 |
| Reich, TC; Summers, WK | 1 |
| Maeda, N; Matsuoka, N; Ohkubo, Y; Yamaguchi, I; Yamazaki, M | 1 |
| Beracochea, D; Jaffard, R; Micheau, J | 1 |
| Maeda, N; Matsuoka, N; Ohkubo, Y; Yamaguchi, I | 1 |
| Volger, BW | 1 |
| Arendt, T; Bigl, V; Schugens, MM | 1 |
| Ebstein, RP; Newman, ME; Shoham, S; Wertman, E | 1 |
| Haigh, JR; Lines, CR; Poppleton, P; Preston, GC; Traub, M; Ward, C | 1 |
| Atack, JR; Chase, TN; Gillespie, M; Gomez, C; Kask, AM; Litvan, I; Mouradian, MM | 1 |
| Riker, WF | 1 |
| Beller, SA; Overall, JE; Rhoades, HM; Swann, AC | 1 |
| Dunnett, SB; Iversen, SD; MacLean, B; Salamone, JD; Welner, SA | 1 |
| Elizur, A; Korczyn, AD; Levin, Y | 1 |
| Beracochea, D; Durkin, TP; Jaffard, R | 1 |
| Nagaoka, A; Nagawa, Y; Yamazaki, N | 1 |
| Davis, KL; Haroutunian, V; Kanof, P | 1 |
| Dysken, MW; Janowsky, DS | 1 |
5 review(s) available for physostigmine and Age-Related Memory Disorders
| Article | Year |
|---|---|
Applications of the P50 evoked response to the evaluation of cognitive impairments after traumatic brain injury.
Topics: Animals; Attention; Brain Injuries; Cholinergic Fibers; Cholinesterase Inhibitors; Cognition Disorders; Evoked Potentials, Auditory; Humans; Memory Disorders; Physostigmine | 2004 |
[Psychopharmacologic treatment of cognitive function disorders in aging persons: current possibilities].
Topics: Adrenocorticotropic Hormone; Aged; Alzheimer Disease; Anticonvulsants; Brain; Catecholamines; Choline; Dementia; Dihydroergotoxine; Humans; Memory Disorders; Narcotic Antagonists; Nerve Tissue Proteins; Neuropsychology; Parasympatholytics; Phosphatidylcholines; Physostigmine; Piracetam; Trace Elements; Vasopressins; Vitamins | 1984 |
Measurement of cholinergic drug effects on memory in Alzheimer's disease.
Topics: Alzheimer Disease; Arecoline; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Humans; Memory; Memory Disorders; Parasympatholytics; Parasympathomimetics; Physostigmine; Scopolamine; Tacrine | 1983 |
Cholinergic underactivity in human memory disorders.
Topics: Aging; Brain Chemistry; Dementia; Humans; Memory Disorders; Parasympathetic Nervous System; Physostigmine; Receptors, Muscarinic | 1978 |
Alternatives in the treatment of memory loss in patients with Alzheimer's disease.
Topics: Alzheimer Disease; Humans; Memory Disorders; Multicenter Studies as Topic; Phosphatidylcholines; Physostigmine; Tacrine | 1991 |
10 trial(s) available for physostigmine and Age-Related Memory Disorders
| Article | Year |
|---|---|
Modulation of fusiform cortex activity by cholinesterase inhibition predicts effects on subsequent memory.
Topics: Aged; Alzheimer Disease; Attention; Brain Mapping; Cholinesterase Inhibitors; Double-Blind Method; Face; Female; Humans; Magnetic Resonance Imaging; Male; Memory; Memory Disorders; Middle Aged; Neural Pathways; Pattern Recognition, Visual; Photic Stimulation; Physostigmine; Reaction Time; Temporal Lobe | 2009 |
Memory decline in the aged: treatment with lecithin and physostigmine.
Topics: Acetylcholine; Adult; Aged; Brain; Cognition; Double-Blind Method; Female; Humans; Learning; Male; Memory Disorders; Memory, Short-Term; Middle Aged; Phosphatidylcholines; Physostigmine; Psychological Tests; Receptors, Cholinergic; Synaptic Transmission | 1982 |
Oral physostigmine and lecithin improve memory in Alzheimer disease.
Topics: Aged; Alzheimer Disease; Clinical Trials as Topic; Dementia; Double-Blind Method; Drug Therapy, Combination; Humans; Memory Disorders; Middle Aged; Phosphatidylcholines; Physostigmine | 1983 |
Measurement of cholinergic drug effects on memory in Alzheimer's disease.
Topics: Alzheimer Disease; Arecoline; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Humans; Memory; Memory Disorders; Parasympatholytics; Parasympathomimetics; Physostigmine; Scopolamine; Tacrine | 1983 |
Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine.
Topics: Aged; Alzheimer Disease; Clinical Trials as Topic; Dementia; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Memory; Memory Disorders; Middle Aged; Physostigmine; Random Allocation | 1982 |
Physostigmine in Alzheimer's disease.
Topics: Adult; Alzheimer Disease; Clinical Trials as Topic; Dementia; Drug Evaluation; Humans; Injections, Subcutaneous; Intelligence Tests; Male; Memory; Memory Disorders; Neuropsychological Tests; Physostigmine; Placebos; Research Design | 1979 |
Alternatives in the treatment of memory loss in patients with Alzheimer's disease.
Topics: Alzheimer Disease; Humans; Memory Disorders; Multicenter Studies as Topic; Phosphatidylcholines; Physostigmine; Tacrine | 1991 |
Physostigmine treatment of progressive supranuclear palsy.
Topics: Aged; Double-Blind Method; Female; Humans; Male; Memory Disorders; Middle Aged; Physostigmine; Supranuclear Palsy, Progressive | 1989 |
Long-term outpatient treatment of senile dementia with oral physostigmine.
Topics: Administration, Oral; Aged; Alzheimer Disease; Ambulatory Care; Clinical Trials as Topic; Female; Humans; Male; Memory Disorders; Middle Aged; Physostigmine; Psychological Tests; Research Design | 1988 |
Physostigmine improves ECT-induced memory disturbances.
Topics: Adolescent; Adult; Electroconvulsive Therapy; Female; Humans; Male; Memory Disorders; Middle Aged; Physostigmine | 1987 |
43 other study(ies) available for physostigmine and Age-Related Memory Disorders
| Article | Year |
|---|---|
In silico studies, synthesis and pharmacological evaluation to explore multi-targeted approach for imidazole analogues as potential cholinesterase inhibitors with neuroprotective role for Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophorus; Female; Horses; Imidazoles; Male; Maze Learning; Memory Disorders; Mice; Molecular Structure; Neuroprotective Agents; Structure-Activity Relationship | 2018 |
Activation of cholinergic system partially rescues olfactory dysfunction-induced learning and memory deficit in mice.
Topics: Animals; Astringents; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Disease Models, Animal; Hippocampus; Male; Memory Disorders; Memory, Long-Term; Memory, Short-Term; Mice; Olfaction Disorders; Olfactory Bulb; Physostigmine; Zinc Sulfate | 2021 |
Critical role of CA1 muscarinic receptors on memory acquisition deficit induced by total (TSD) and REM sleep deprivation (RSD).
Topics: Animals; CA1 Region, Hippocampal; Cholinesterase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Memory; Memory Disorders; Motor Activity; Muscarinic Antagonists; Nootropic Agents; Physostigmine; Rats, Wistar; Receptors, Muscarinic; Scopolamine; Sleep Deprivation; Sleep, REM | 2017 |
An animal model of fetal alcohol spectrum disorder: Trace conditioning as a window to inform memory deficits and intervention tactics.
Topics: Adolescent; Age Factors; Analysis of Variance; Animals; Animals, Newborn; Body Weight; Central Nervous System Depressants; Child; Choline; Conditioning, Classical; Disease Models, Animal; Ethanol; Fetal Alcohol Spectrum Disorders; Humans; Memory Disorders; Nootropic Agents; Physostigmine; Rats; Rats, Sprague-Dawley; Reaction Time | 2015 |
Possible role of cholinesterase inhibitors on memory consolidation following hypobaric hypoxia of rats.
Topics: Acetylcholine; Air Pressure; Altitude Sickness; Animals; Cholinesterase Inhibitors; Disease Models, Animal; Galantamine; Hypoxia, Brain; Male; Maze Learning; Memory; Memory Disorders; Physostigmine; Rats; Rats, Sprague-Dawley; Time Factors; Treatment Outcome | 2011 |
Cholinesterase inhibitors improve both memory and complex learning in aged beagle dogs.
Topics: Aging; Analysis of Variance; Animals; Behavior, Animal; Cholinergic Antagonists; Cholinesterase Inhibitors; Discrimination, Psychological; Disease Models, Animal; Dogs; Donepezil; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Indans; Learning Disabilities; Male; Memory Disorders; Neuropsychological Tests; Odorants; Physostigmine; Piperidines; Scopolamine | 2011 |
Lithium, phenserine, memantine and pioglitazone reverse memory deficit and restore phospho-GSK3β decreased in hippocampus in intracerebroventricular streptozotocin induced memory deficit model.
Topics: Animals; Conditioning, Classical; Disease Models, Animal; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Hippocampus; Hypoglycemic Agents; Infusions, Intraventricular; Lithium; Male; Memantine; Memory Disorders; Neuroprotective Agents; Physostigmine; Pioglitazone; Prefrontal Cortex; Rats; Rats, Wistar; Statistics, Nonparametric; Streptozocin; Thiazolidinediones | 2011 |
Involvement of reduced acetylcholine release in Delta9-tetrahydrocannabinol-induced impairment of spatial memory in the 8-arm radial maze.
Topics: Acetylcholine; Animals; Cerebral Cortex; Cholinesterase Inhibitors; Cognition Disorders; Dronabinol; Hallucinogens; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Microdialysis; Physostigmine; Rats; Rats, Wistar; Space Perception; Tacrine | 2002 |
Atropine, an anticholinergic drug, impairs memory retrieval of a high consolidated avoidance response in mice.
Topics: Animals; Atropine; Avoidance Learning; Behavior, Animal; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Male; Memory Disorders; Mice; Muscarinic Antagonists; Physostigmine; Reaction Time | 2003 |
Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Behavior, Animal; Cholinesterase Inhibitors; Conditioning, Psychological; Disease Models, Animal; Donepezil; Dose-Response Relationship, Drug; Fear; Genetics, Behavioral; Heterozygote; Humans; Indans; Learning; Memory; Memory Disorders; Mice; Mice, Transgenic; Physostigmine; Piperidines; Plaque, Amyloid; Spatial Behavior | 2005 |
Alterations in cognitive function in prepubertal mice with protein malnutrition: relationship to changes in choline acetyltransferase.
Topics: Age Factors; Animals; Animals, Newborn; Behavior, Animal; Body Weight; Brain; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Immunohistochemistry; Male; Memory Disorders; Mice; Physostigmine; Protein Deficiency; Reaction Time; Time Factors | 2006 |
Age-related changes in memory and in acetylcholine functions in the hippocampus in the Ts65Dn mouse, a model of Down syndrome.
Topics: Acetylcholine; Age Factors; Animals; Cholinesterase Inhibitors; Disease Models, Animal; Down Syndrome; Hippocampus; Memory Disorders; Mice; Microdialysis; Physostigmine; Septum Pellucidum | 2008 |
Long-term administration of oral physostigmine and lecithin improve memory in Alzheimer's disease.
Topics: Administration, Oral; Alzheimer Disease; Humans; Memory Disorders; Phosphatidylcholines; Physostigmine | 1984 |
Research subject recruitment for gerontological studies of pharmacological agents.
Topics: Aged; Aging; Alzheimer Disease; Clinical Trials as Topic; Female; Humans; Male; Memory Disorders; Middle Aged; Physostigmine | 1982 |
Physostigmine, but not 3,4-diaminopyridine, improves radial maze performance in memory-impaired rats.
Topics: 4-Aminopyridine; Amifampridine; Animals; Cerebral Cortex; Choline O-Acetyltransferase; Dose-Response Relationship, Drug; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Physostigmine; Potassium Channels; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Scopolamine | 1995 |
NS-3(CG3703), a TRH analog, ameliorates scopolamine-induced memory disruption in rats.
Topics: Animals; Male; Maze Learning; Memory Disorders; Physostigmine; Rats; Rats, Wistar; Scopolamine; Thyrotropin-Releasing Hormone | 1995 |
Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice.
Topics: Analgesics; Animals; Behavior, Animal; Drug Interactions; Dynorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Male; Memory; Memory Disorders; Mice; Mice, Inbred Strains; Peptide Fragments; Physostigmine; Receptors, Opioid, mu | 1994 |
MK-801 impairs recognition memory in rhesus monkeys: comparison with cholinergic drugs.
Topics: Animals; Dizocilpine Maleate; Dose-Response Relationship, Drug; Learning; Learning Disabilities; Macaca mulatta; Male; Memory; Memory Disorders; Physostigmine; Scopolamine | 1993 |
Effect of cholinergic activation by physostigmine on working memory failure caused in rats by pharmacological manipulation of hippocampal glutamatergic and 5-HTergic neurotransmission.
Topics: Acetylcholine; Animals; Cholinesterase Inhibitors; Excitatory Amino Acid Antagonists; Glutamic Acid; Hippocampus; Male; Memory Disorders; Memory, Short-Term; Muscarinic Antagonists; Physostigmine; Rats; Rats, Wistar; Scopolamine; Serotonin; Serotonin Receptor Agonists; Synaptic Transmission | 1996 |
Effects of cholinergic drugs on scopolamine-induced memory impairment in rhesus monkeys.
Topics: Animals; Arecoline; Cholinesterase Inhibitors; Macaca mulatta; Male; Memory; Memory Disorders; Muscarinic Agonists; Nicotine; Nicotinic Agonists; Physostigmine; Scopolamine | 1996 |
Donepezil medicated memory improvement in traumatic brain injury during post acute rehabilitation.
Topics: Adult; Alzheimer Disease; Brain Injuries; Cholinesterase Inhibitors; Cognitive Behavioral Therapy; Donepezil; Female; Head Injuries, Closed; Humans; Indans; Male; Memory; Memory Disorders; Mental Recall; Middle Aged; Physical Therapy Modalities; Physostigmine; Piperidines; Temporal Lobe | 1998 |
Effect of the subchronic treatment with the acetylcholinesterase inhibitor heptastigmine on central cholinergic transmission and memory impairment in aged rats.
Topics: Acetylcholinesterase; Aging; Animals; Behavior, Animal; Brain; Cholinesterase Inhibitors; Cognition; Male; Memory Disorders; Parasympathetic Nervous System; Physostigmine; Rats; Rats, Wistar; Space Perception; Synaptic Transmission | 1998 |
Gender differences in the effect of rivastigmine on brain cholinesterase activity and cognitive function in rats.
Topics: Animals; Brain; Carbamates; Cholinesterase Inhibitors; Cholinesterases; Female; Male; Memory; Memory Disorders; Muscarinic Antagonists; Muscle, Skeletal; Myocardium; Orchiectomy; Ovariectomy; Phenylcarbamates; Physostigmine; Rats; Rats, Sprague-Dawley; Rivastigmine; Scopolamine; Sex Factors | 2000 |
Cannabinoid-induced working memory impairment is reversed by a second generation cholinesterase inhibitor in rats.
Topics: Animals; Behavior, Animal; Cannabinoids; Cholinesterase Inhibitors; Cyclohexanols; Male; Maze Learning; Memory; Memory Disorders; Motor Activity; Physostigmine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Rimonabant | 2000 |
Cholinergic and glutamatergic activation reverses working memory failure by hippocampal histamine H1 receptor blockade in rats.
Topics: Acetylcholine; Animals; Cholinesterase Inhibitors; Cimetidine; Cycloserine; Drug Interactions; Glutamic Acid; Hippocampus; Histamine Agonists; Histamine H1 Antagonists; Histamine H2 Antagonists; Male; Memory; Memory Disorders; Neurons; Physostigmine; Pyridines; Pyrilamine; Rats; Rats, Wistar; Receptors, Histamine H1; Receptors, N-Methyl-D-Aspartate | 2000 |
Reversal of morphine-induced memory impairment in mice by withdrawal in Morris water maze: possible involvement of cholinergic system.
Topics: Animals; Cholinergic Antagonists; Dose-Response Relationship, Drug; Injections, Subcutaneous; Male; Maze Learning; Memory Disorders; Mice; Morphine; Motivation; Muscarinic Agonists; Muscarinic Antagonists; Naloxone; Narcotic Antagonists; Narcotics; Oxotremorine; Parasympathetic Nervous System; Physostigmine; Scopolamine; Substance Withdrawal Syndrome | 2001 |
Involvement of cholinergic and glutamatergic functions in working memory impairment induced by interleukin-1beta in rats.
Topics: Analysis of Variance; Animals; Cycloserine; Dose-Response Relationship, Drug; Hippocampus; Interleukin-1; Male; Memory; Memory Disorders; Physostigmine; Rats; Rats, Wistar; Receptors, Cholinergic; Receptors, N-Methyl-D-Aspartate | 2001 |
Reversal of the memory-disruptive effects of REM sleep deprivation by physostigmine.
Topics: Animals; Avoidance Learning; Humans; Male; Memory; Memory Disorders; Motor Activity; Physostigmine; Rats; Scopolamine; Sleep Deprivation; Sleep, REM; Time Factors | 1976 |
Physostigmine and recent memory: effects in young and aged nonhuman primates.
Topics: Acetylcholine; Aging; Animals; Cognition; Female; Haplorhini; Humans; Male; Memory; Memory Disorders; Memory, Short-Term; Physostigmine; Synaptic Transmission | 1979 |
Delirium after cataract surgery: review and two cases.
Topics: Aged; Cataract Extraction; Delirium; Drug Synergism; Female; Humans; Male; Memory Disorders; Mental Status Schedule; Middle Aged; Mydriatics; Parasympatholytics; Physostigmine; Psychotropic Drugs; Time Factors | 1979 |
Possible biochemical basis of memory disorder in Alzheimer's disease.
Topics: Adult; Alzheimer Disease; Dementia; Humans; Male; Memory; Memory Disorders; Physostigmine | 1979 |
Effect of FR121196, a novel cognitive enhancer, on the memory impairment of rats in passive avoidance and radial arm maze tasks.
Topics: Aging; Animals; Avoidance Learning; Brain; Choline O-Acetyltransferase; Cognition Disorders; Dementia; Discrimination Learning; Disease Models, Animal; Male; Memory Disorders; Methamphetamine; Motor Activity; Physostigmine; Piperazines; Rats; Rats, Inbred F344; Rats, Wistar; Scopolamine; Sulfonamides | 1992 |
Memory deficits following chronic alcohol consumption in mice: relationships with hippocampal and cortical cholinergic activities.
Topics: Acetylcholine; Animals; Brain Chemistry; Cerebral Cortex; Choline; Ethanol; Exploratory Behavior; Hippocampus; Male; Memory Disorders; Mice; Mice, Inbred BALB C; Parasympathetic Nervous System; Physostigmine | 1992 |
Differential effects of physostigmine and pilocarpine on the spatial memory deficits produced by two septo-hippocampal deafferentations in rats.
Topics: Animals; Choline O-Acetyltransferase; Hippocampus; Male; Memory Disorders; Neurons, Afferent; Physostigmine; Pilocarpine; Rats; Rats, Inbred F344; Space Perception; Stereotaxic Techniques | 1991 |
The cholinergic system and memory: amelioration of ethanol-induced memory deficiency by physostigmine in rat.
Topics: Acetylcholine; Acetylcholinesterase; Alcoholism; Animals; Brain; Choline; Choline O-Acetyltransferase; Male; Memory Disorders; Physostigmine; Rats; Rats, Inbred Strains | 1990 |
Cortical second messengers after NBM damage: no change in responses to cholinergic agonists.
Topics: Acetylcholine; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Basal Ganglia; Carbachol; Cerebral Cortex; Cyclic AMP; Inositol Phosphates; Male; Memory Disorders; Physostigmine; Rats; Second Messenger Systems; Substantia Innominata | 1990 |
Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmine.
Topics: Acoustic Stimulation; Adult; Anti-Anxiety Agents; Attention; Cognition Disorders; Dementia; Disease Models, Animal; Female; Flumazenil; Humans; Male; Memory Disorders; Photic Stimulation; Physostigmine; Psychomotor Performance; Pupil; Reaction Time; Scopolamine | 1989 |
Memory impairment in myasthenia gravis.
Topics: Cognition Disorders; Humans; Memory Disorders; Myasthenia Gravis; Physostigmine; Pyridostigmine Bromide | 1989 |
Transplantation of embryonic ventral forebrain grafts to the neocortex of rats with bilateral lesions of nucleus basalis magnocellularis ameliorates a lesion-induced deficit in spatial memory.
Topics: Acetylcholinesterase; Animals; Basal Ganglia; Cerebral Cortex; Cholinergic Fibers; Frontal Lobe; Male; Memory Disorders; Oxadiazoles; Physostigmine; Quisqualic Acid; Rats; Rats, Inbred Strains; Spatial Behavior | 1988 |
On the involvement of the central cholinergic system in memory deficits induced by long term ethanol consumption in mice.
Topics: Alcoholism; Animals; Behavior, Animal; Body Weight; Brain Chemistry; Choline; Energy Intake; Hippocampus; Kinetics; Male; Memory Disorders; Mice; Mice, Inbred BALB C; Parasympathetic Nervous System; Physostigmine; Sodium; Synaptosomes | 1986 |
[Effect of idebenone on scopolamine-induced impairment of short-term memory in rats].
Topics: Animals; Benzoquinones; Brain; Cholinergic Fibers; Male; Memory Disorders; Memory, Short-Term; Physostigmine; Quinones; Rats; Rats, Inbred Strains; Scopolamine; Ubiquinone | 1985 |
Pharmacological alleviation of cholinergic lesion induced memory deficits in rats.
Topics: Alzheimer Disease; Animals; Basal Ganglia; Cholinergic Fibers; Humans; Male; Memory Disorders; Motor Activity; Physostigmine; Rats; Rats, Inbred Strains; Substantia Innominata; Time Factors | 1985 |
Dose-related physostigmine-induced ventricular arrhythmia: case report.
Topics: Aged; Alzheimer Disease; Arrhythmias, Cardiac; Double-Blind Method; Humans; Male; Memory Disorders; Physostigmine; Placebos | 1985 |